Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Danyelle Garcia
Institution:
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Observed institutions:
Northwestern University,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
ORCID:
0009-0002-3765-932X
Observed ORCID:
0009-0002-3765-932X
OpenAlex ID:
A5137041768
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026
·
Rimas V. Lukas
, Lijie Zhai
, et al.
·
Clinical Cancer Research
·
4
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205
2025
·
Derek Wainwright
, Rimas Lukas
, et al.
·
Research Square
·
1
PDF
Data Source1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026
·
Rimas V. Lukas
, Lijie Zhai
, et al.
Supplementary Tables1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026
·
Rimas V. Lukas
, Lijie Zhai
, et al.
Supplementary Figures1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026
·
Rimas V. Lukas
, Lijie Zhai
, et al.
Data from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205
2026
·
Rimas V. Lukas
, Lijie Zhai
, et al.
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type